95 related articles for article (PubMed ID: 31792839)
1. Integrin α6-Targeted Magnetic Resonance Imaging of Hepatocellular Carcinoma in Mice.
Zhang Y; Zhao J; Cai J; Ye JC; Xiao YT; Mei Y; Zeng MS; Xie CM; Jiang Y; Feng GK
Mol Imaging Biol; 2020 Aug; 22(4):864-872. PubMed ID: 31792839
[TBL] [Abstract][Full Text] [Related]
2. Magnetic-optical dual-modality imaging monitoring chemotherapy efficacy of pancreatic ductal adenocarcinoma with a low-dose fibronectin-targeting Gd-based contrast agent.
Zhang W; Liang X; Zhang X; Tong W; Shi G; Guo H; Jin Z; Tian J; Du Y; Xue H
Eur J Nucl Med Mol Imaging; 2024 Jun; 51(7):1841-1855. PubMed ID: 38372766
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and evaluation of globular Gd-DOTA-monoamide conjugates with precisely controlled nanosizes for magnetic resonance angiography.
Kaneshiro TL; Jeong EK; Morrell G; Parker DL; Lu ZR
Biomacromolecules; 2008 Oct; 9(10):2742-8. PubMed ID: 18771313
[TBL] [Abstract][Full Text] [Related]
4. A Dual-Modality MR/PA Imaging Contrast Agent Based on Ultrasmall Biopolymer Nanoparticles for Orthotopic Hepatocellular Carcinoma Imaging.
Sun J; Li X; Chen A; Cai W; Peng X; Li L; Fan B; Wang L; Zhang H; Zhang R
Int J Nanomedicine; 2019; 14():9893-9904. PubMed ID: 31908447
[TBL] [Abstract][Full Text] [Related]
5. Preparation and performance of biocompatible gadolinium polymer as liver-targeting magnetic resonance imaging contrast agent.
Hu T; Wan C; Zhan Y; Li X; Zheng Y
J Biosci Bioeng; 2024 Feb; 137(2):134-140. PubMed ID: 38195341
[TBL] [Abstract][Full Text] [Related]
6. An NIR-II/MR dual modal nanoprobe for liver cancer imaging.
Ren Y; He S; Huttad L; Chua MS; So SK; Guo Q; Cheng Z
Nanoscale; 2020 Jun; 12(21):11510-11517. PubMed ID: 32428058
[TBL] [Abstract][Full Text] [Related]
7. Chiral Gd-DOTA as a Versatile Platform for Hepatobiliary and Tumor Targeting MRI Contrast Agents.
Xu W; Ye X; Wu M; Jiang X; Hugo Tse LH; Gu Y; Shu K; Xu L; Jian Y; Mo G; Xu J; Ding Y; Gao R; Shen J; Ye F; Yan Z; Dai L
J Med Chem; 2023 Nov; 66(21):14669-14682. PubMed ID: 37855413
[TBL] [Abstract][Full Text] [Related]
8. cRGD peptide-conjugated icosahedral closo-B12(2-) core carrying multiple Gd3+-DOTA chelates for α(v)β3 integrin-targeted tumor imaging (MRI).
Goswami LN; Ma L; Cai Q; Sarma SJ; Jalisatgi SS; Hawthorne MF
Inorg Chem; 2013 Feb; 52(4):1701-9. PubMed ID: 23391150
[TBL] [Abstract][Full Text] [Related]
9. Next-Generation Cancer Magnetic Resonance Imaging With Tumor-Targeted Alkylphosphocholine Metal Analogs.
Zhang RR; Choi C; Brunnquell CL; Hernandez R; Pinchuk AN; Grudzinski JG; Clark PA; McMillan AB; Audhya A; Jeffrey J; Kuo JS; Weichert JP
Invest Radiol; 2022 Oct; 57(10):655-663. PubMed ID: 36069439
[TBL] [Abstract][Full Text] [Related]
10. Lumazine Synthase Protein Nanoparticle-Gd(III)-DOTA Conjugate as a T1 contrast agent for high-field MRI.
Song Y; Kang YJ; Jung H; Kim H; Kang S; Cho H
Sci Rep; 2015 Oct; 5():15656. PubMed ID: 26493381
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous enhancement of T
Li H; Hai Z; Zou L; Zhang L; Wang L; Wang L; Liang G
Theranostics; 2022; 12(1):410-417. PubMed ID: 34987653
[No Abstract] [Full Text] [Related]
12. Dynamic, Simultaneous Concentration Mapping of Multiple MRI Contrast Agents with Dual Contrast - Magnetic Resonance Fingerprinting.
Anderson CE; Johansen M; Erokwu BO; Hu H; Gu Y; Zhang Y; Kavran M; Vincent J; Drumm ML; Griswold MA; Steinmetz NF; Li M; Clark H; Darrah RJ; Yu X; Brady-Kalnay SM; Flask CA
Sci Rep; 2019 Dec; 9(1):19888. PubMed ID: 31882792
[TBL] [Abstract][Full Text] [Related]
13. MRI detection of breast cancer micrometastases with a fibronectin-targeting contrast agent.
Zhou Z; Qutaish M; Han Z; Schur RM; Liu Y; Wilson DL; Lu ZR
Nat Commun; 2015 Aug; 6():7984. PubMed ID: 26264658
[TBL] [Abstract][Full Text] [Related]
14. A targeted nanoglobular contrast agent from host-guest self-assembly for MR cancer molecular imaging.
Zhou Z; Han Z; Lu ZR
Biomaterials; 2016 Apr; 85():168-79. PubMed ID: 26874280
[TBL] [Abstract][Full Text] [Related]
15. Sol and gel states in peptide hydrogels visualized by Gd(III)-enhanced magnetic resonance imaging.
Weerasekare M; Taraban MB; Shi X; Jeong EK; Trewhella J; Yu YB
Biopolymers; 2011; 96(6):734-43. PubMed ID: 22252424
[TBL] [Abstract][Full Text] [Related]
16. Gadolinium-Based Magnetic Resonance Theranostic Agent with Gallic Acid as an Anti-Neuroinflammatory and Antioxidant Agent.
Sung B; Hwang D; Baek A; Yang B; Lee S; Park J; Kim E; Kim M; Lee E; Chang Y
Antioxidants (Basel); 2024 Feb; 13(2):. PubMed ID: 38397802
[TBL] [Abstract][Full Text] [Related]
17. Editorial for "Quantitative MRI of Gd-DOTA Accumulation in the Mouse Brain After Intraperitoneal Administration: Validation by Mass Spectrometry".
Geethanath S
J Magn Reson Imaging; 2023 Sep; ():. PubMed ID: 37776098
[No Abstract] [Full Text] [Related]
18. CpG-Oligodeoxynucleotides Alleviate Tert-Butyl Hydroperoxide-Induced Macrophage Apoptosis by Regulating Mitochondrial Function and Suppressing ROS Production.
Qu Y; Yang C; Li X; Luo H; Li S; Niu M; Chen P; Yan Z; Jiang Y
Oxid Med Cell Longev; 2020; 2020():1714352. PubMed ID: 32454932
[TBL] [Abstract][Full Text] [Related]
19. Data-Independent Acquisition-Based Quantitative Proteomics Analysis Reveals Dynamic Network Profiles during the Macrophage Inflammatory Response.
Li L; Chen L; Lu X; Huang C; Luo H; Jin J; Mei Z; Liu J; Liu C; Shi J; Chen P; Jiang Y
Proteomics; 2020 Jan; 20(2):e1900203. PubMed ID: 31876377
[TBL] [Abstract][Full Text] [Related]
20. An optimized integrin α6-targeted peptide for positron emission tomography/magnetic resonance imaging of pancreatic cancer and its precancerous lesion.
Mei Y; Li YH; Yang XC; Zhou C; Li ZJ; Zheng XB; Ye JC; Li C; Zhang XH; Yuan JM; Huang HQ; Fan W; Zhang WG; Zeng MS; Feng GK
Clin Transl Med; 2020 Aug; 10(4):e157. PubMed ID: 32898323
[No Abstract] [Full Text] [Related]
[Next] [New Search]
